BioCentury
ARTICLE | Finance

JOBS Jolt 3.0?

Assessing the benefits of JOBS 3.0 for biotechs looking to go public

July 20, 2018 10:52 PM UTC

The latest iteration of the JOBS Act could make it easier for biotechs to go public -- and raise more money more quickly -- but that doesn’t necessarily mean the quality of the IPO queue will be diluted.

The House of Representatives voted 406-4 on Tuesday to pass the JOBS and Investor Confidence Act of 2018, or JOBS Act 3.0, a collection of 32 bills that expands upon provisions enacted in 2012 (see “Tear Down That Wall”)...